Article
Biologic therapies for lupus nephritis: a systematic review of efficacy, safety, and cost-effectiveness
2025-09-30
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> Lupus nephritis is a major cause of kidney failure worldwide, disproportionately affecting Black, Hispanic, and Asian populations. Standard regimens with mycophenolate mofetil or cyclophosphamide and glucocorticoids remain suboptimal, with many patients experiencing incomplete responses, relapses, or drug-related toxicity. Recently approved biologic and target...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4a65619b-5669-5da8-ad87-ea0d4822c60b
- DOI
- 10.21203/rs.3.rs-7608456/v1